comparemela.com

Latest Breaking News On - வ்க் கையகப்படுத்தல் கார்ப் - Page 10 : comparemela.com

SHAREHOLDER ALERT: WeissLaw LLP Reminds CLGX, VGAC, ANDA and HEC Shareholders About Its Ongoing Investigations

2 Healthcare SPACs to Watch in 2021 | The Motley Fool

SPAC: The Music Business New Fave IPO Strategy

4 takeaways from 23&Me s planned SPAC deal

MedCity News 4 takeaways from 23&Me’s planned SPAC deal Consumer DNA testing company 23andMe plans to go public through a merger with a special-purpose acquisition company started by Virgin Group. As sales of DNA testing kits wane, how will 23andMe drum up new interest for its business? Shares0 As sales for DNA testing kits flatten, the companies that make them are faced with a predicament. Revenues are falling as the market became saturated, and more consumers began to wonder about the privacy of their data. After a bumpy 2020, consumer DNA testing company 23andMe plans to go public through a blank-check deal. The Sunnyvale, Calif.-based business will merge with a special-purpose acquisition company started by Virgin Group in a deal that would value it at $3.5 billion.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.